Meropenem and imipenem activity against Pseudomonas aeruginosa isolates from the MYSTIC Program

被引：16
|
作者：
Turner, Philip J. [1 ]
机构：
[1] AstraZeneca, Infect Discovery Dept, Macclesfield SK10 4TG, Cheshire, England
来源：
DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE | 2006年 / 56卷 / 03期
关键词：
Pseudomonas aeruginosa; susceptibility; meropenem; imipenem;
D O I：
10.1016/j.diagmicrobio.2006.07.015
中图分类号：
R51 [传染病];
学科分类号：
100401 ;
摘要：
This article examines the activity of meropenem and imipenem against Pseudomonas aeruginosa isolates from the Meropenem Yearly Susceptibility Test Information Collection program between 1997 and 2005. In particular, it examines the activity of meropenem against imipenem-resistant strains and vice versa. Meropenem proved to be active against up to a 3rd of imipenem-resistant strains. (c) 2006 Elsevier Inc. All rights reserved.
引用
收藏
页码：341 / 344
页数：4
相关论文
共 50 条
  • [1] In vitro activity of meropenem, imipenem, cefepime and ceftazidime against Pseudomonas aeruginosa isolates from cystic fibrosis patients
    Christenson, JC
    Korgenski, EK
    Daly, JA
    [J]. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2000, 45 (06) : 899 - 901
  • [2] Comparative in vitro pharmacodynamics of imipenem and meropenem against Pseudomonas aeruginosa
    White, R
    Friedrich, L
    Burgess, D
    Warkentin, D
    Bosso, J
    [J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1996, 40 (04) : 904 - 908
  • [3] IN VITRO ACTIVITY OF IMIPENEM/RELEBACTAM AGAINST PSEUDOMONAS AERUGINOSA ISOLATES FROM US HOSPITALS
    Asempa, Tomefa
    Nicolau, David
    Kuti, Joseph
    [J]. CRITICAL CARE MEDICINE, 2019, 47
  • [4] Activity of meropenem and comparators against Pseudomonas aeruginosa and Acinetobacter spp. isolated in the MYSTIC Program, 2002-2004
    Unal, S
    Garcia-Rodriguez, JA
    [J]. DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE, 2005, 53 (04) : 265 - 271
  • [5] In vitro antibacterial activity of rifampicin in combination with imipenem, meropenem and doripenem against multidrug-resistant clinical isolates of Pseudomonas aeruginosa
    Hu, Yi-Fan
    Liu, Chang-Pan
    Wang, Nai-Yu
    Shih, Shou-Chuan
    [J]. BMC INFECTIOUS DISEASES, 2016, 16
  • [6] In vitro antibacterial activity of rifampicin in combination with imipenem, meropenem and doripenem against multidrug-resistant clinical isolates of Pseudomonas aeruginosa
    Yi-Fan Hu
    Chang-Pan Liu
    Nai-Yu Wang
    Shou-Chuan Shih
    [J]. BMC Infectious Diseases, 16
  • [7] Pharmacodynamics of meropenem and imipenem against Enterobacteriaceae, Acinetobacter baumannii, and Pseudomonas aeruginosa
    Kuti, JL
    Florea, NR
    Nightingale, CH
    Nicolau, DP
    [J]. PHARMACOTHERAPY, 2004, 24 (01): : 8 - 15
  • [8] Evaluation and study of antimicrobial activity of nanoliposomal meropenem against Pseudomonas aeruginosa isolates
    Zahra, Momeni-Javid
    Hamed, Hamishekar
    Mohammad, Rahmati-Yamchi
    Nosratollah, Zarghami
    Akbarzadeh, Abolfazl
    Morteza, Milani
    [J]. ARTIFICIAL CELLS NANOMEDICINE AND BIOTECHNOLOGY, 2017, 45 (05) : 975 - 980
  • [9] In vitro activity of meropenem in combination with ciprofloxacin against clinical isolates of Pseudomonas aeruginosa
    Solak, S
    Willke, A
    Ergönül, Ö
    Tekeli, E
    [J]. INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS, 2005, 25 (02) : 181 - 182
  • [10] BACTERICIDAL ACTIVITY OF MEROPENEM AGAINST PSEUDOMONAS-AERUGINOSA
    YOURASSOWSKY, E
    VANDERLINDEN, MP
    LISMONT, MJ
    CROKAERT, F
    GLUPCZYNSKI, Y
    [J]. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 1989, 24 : 169 - 174
12345